Healthy Skepticism Library item: 9382

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Conlan MF.
Congress leaves mixed record, with much to revisit in "93
Drug Topics 1992 Nov 9; 136:82, 84, 88

Abstract:

The passage of a bill to levy fees on the pharmaceutical industry to promote reduced review times at the U.S. Food and Drug Administration through the hiring of 600 reviewers is discussed, and legislation that was considered but not passed is described, including flat rate discounts, prescription price control, insurance antitrust, and a third class of drugs.